Shingrix is a vaccine indicated for the prevention of herpes zoster in adults aged 50 years or older and those 18 years or older who are at a ... ... <看更多>
「zoster-049」的推薦目錄：
zoster-049 在 A Study on the Long-term Efficacy, Safety and Persistence ... 的相關結果
In the current ZOSTER-101 study, this Control group is used in the evaluation of the long-term vaccine efficacy, safety and as a control for ... ... <看更多>
zoster-049 在 Zoster Vaccine Recombinant,Adjuvanted (Shingrix®) 的相關結果
Zoster -049 Study Group. The Adjuvanted. Recombinant Zoster Vaccine Confers. Long-Term Protection Against Herpes Zoster: Interim Results of an Extension ... ... <看更多>
zoster-049 在 201190 (Zoster-049) 的相關結果
Shingles is an infection that is caused by the same virus that causes chickenpox. After getting chickenpox during childhood, the virus remains in the body. ... <看更多>
zoster-049 在 New data show Shingrix can provide at least 10 years of ... 的相關結果
The ZOSTER-049 extension study shows that Shingrix can provide at least a decade of protection against shingles after initial vaccination. ... <看更多>
zoster-049 在 Efficacy Data - Shingles Vaccine 的相關結果
Zoster -049 Study Group. Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety ... ... <看更多>
zoster-049 在 Demographic characteristics of participants included in the ... 的相關結果
Demographic characteristics of participants included in the ZOSTER-049 study, for the analysis of vaccine efficacy against herpes zoster (mTVC). ... <看更多>
zoster-049 在 GSK's ZOSTER-049 extension study data shows Shingrix ... 的相關結果
ZOSTER -049 is an open-label, long-term follow-up (LTFU) study from two pivotal phase III randomised clinical trials (ZOE-50, ZOE-70). The study ... ... <看更多>
zoster-049 在 GSK's Shingrix shows to offer ten years of shingles ... 的相關結果
ZOSTER -049 is an open-label, long-term follow-up study from two Phase III randomised clinical trials, ZOE-50 and ZOE-70. Recommended Reports. ... <看更多>
zoster-049 在 Shingrix (herpes zoster vaccine recombinant, adjuvanted) 的相關結果
Follow-up period during interim analysis: ≥4 years in ZOSTER-049, until DLP - Mean 5.6 (±0.3) to 9.6 (±0.3) years post-vaccination in ZOE-50/70. HZ cases (n/N) ... ... <看更多>
zoster-049 在 Interim Results of an Extension Study (ZOSTER-049) ... 的相關結果
In this extension study (ZOSTER-049 [NCT02723773]), RZV-induced immunogenicity persistence and long-term vaccine efficacy (VE) again. ... <看更多>
zoster-049 在 114. Long-term Protection Against Herpes Zoster (HZ) by ... 的相關結果
No safety signals were identified until the end of Y4 of ZOSTER-049. Conclusion. Efficacy against HZ and immune responses to RZV remained high ... ... <看更多>
zoster-049 在 The Adjuvanted Recombinant Zoster Vaccine Confers 的相關結果
*Zoster-049 Study Group members are listed below the Supplementary Data section. aPresent affiliation: GSK, Wavre, Belgium. ... <看更多>
zoster-049 在 Summary of risk management plan for Shingrix 的相關結果
Shingrix is authorised for prevention of herpes zoster (HZ) and post-herpetic neuralgia (PHN), ... Short study name: ZOSTER-049, ZOSTER-073. See section II. ... <看更多>
zoster-049 在 Zoster-049 - CEEIV - Centros FISABIO - Generalitat Valenciana 的相關結果
Vacuna contra el Herpes Zóster en sujetos que previamente en sujetos que previamente recibieron la vacuna HZ/su en los estudios ZOSTER-006 y ... Zóster-049 ... ... <看更多>
zoster-049 在 GSK's shingles vaccine demonstrates at least ten-year ... 的相關結果
The findings from [ZOSTER-049] demonstrate that it can provide a decade of protection against the pain, debilitating impact and potentially ... ... <看更多>
zoster-049 在 Infectious Disease Special Edition 的相關結果
The adjuvanted recombinant zoster vaccine (RZV; Shingrix, ... and ZOSTER-049 long-term follow-up efficacy study, funded by GSK. ... <看更多>
zoster-049 在 Zoster-049:Efficacy, safety and immunogenicity of GSK ... 的相關結果
Registeranmälan Zoster-049, PUL-anmälan "Zoster-049:Efficacy, safety and immunogenicity of GSK Biologicals' HZ/su vaccine GSK1437173A in a phase IIIb, ... ... <看更多>
zoster-049 在 Recombinant Zoster Vaccine Protection Durable at 10 ... 的相關結果
Efficacy of the RZV vaccine against herpes zoster infection remained >80% in ... The results come from an interim analysis of the ZOSTER-049 ... ... <看更多>
zoster-049 在 A study on the long-term efficacy, safety and persistence of ... 的相關結果
... long-term follow-up study of ZOSTER-049 (follow-up of ZOSTER-006/022 studies) ... safety and persistence of immune response of a Herpes Zoster subunit ... ... <看更多>
zoster-049 在 GSK's Shingrix offers 10 years of protection for older adults 的相關結果
The ongoing follow-up study Zoster-049 is tracking patients from two prior ... Older adults are at higher risk of developing shingles and ... ... <看更多>
zoster-049 在 葛兰素史克：ZOSTER-049扩展研究取得积极中期结果 的相關結果
葛兰素史克(GSK)今日宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护。 ... <看更多>
zoster-049 在 Data Show Shingrix Offers 10 Years of Protection Against ... 的相關結果
ZOSTER -049 was an extension from a pair of phase 3 clinical trials, ZOE-50 and ZOE-70, in which the efficacy of Shingrix was 97% in adults ... ... <看更多>
zoster-049 在 Shingles Vaccine Safe, Effective Up to 10 Years After ... 的相關結果
Shingrix provides long-term protection against herpes zoster infection for at least ... from the ZOE-50 and ZOE-70 parent studies, and ZOSTER-049 long-term ... ... <看更多>
zoster-049 在 List of Clinical Trials - KWM Juliusspital 的相關結果
assess the immunogenicity and safety of Herpes Zoster vaccine co- administered with Prevenar13 in adjults ... (Zoster-049 GSK-201190). EudraCT-Nummer 2015-. ... <看更多>
zoster-049 在 Phase III ZOSTER-049 extension study shows that Shingrix ... 的相關結果
These results come from ZOSTER-049 (ZOE-LTFU), an extension from two phase III clinical trials ZOE-50 and ZOE-70. ... <看更多>
zoster-049 在 varicella-zoster-vaccine-psd-03-2023. ... 的相關結果
ZOSTER -049: Long-term follow-up study (ongoing) of ZOE-50 and ZOE-70 participants with interim analysis for vaccine efficacy against HZ (VEHZ) (N=7,277). The ... ... <看更多>
zoster-049 在 重组带状疱疹疫苗欣安立适能够为50岁及以上成人提供至少 ... 的相關結果
葛兰素史克（GSK）今日宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护。 ... <看更多>
zoster-049 在 Présentation PowerPoint 的相關結果
Phase III and non-interventional studies. ZOSTER-049, 060. ZOSTER-064, 063. ZOSTER-069. ZOSTER-002, 039, 041, 028. ZOSTER-062, 056. EPI-ZOSTER-031. ... <看更多>
zoster-049 在 La vacuna recombinante contra el herpes zóster, en ... 的相關結果
The recombinant herpes zoster vaccine, in growing expansion and with more ... del estudio Zoster-049, donde se ha observado como la inmunogenicidad, ... ... <看更多>
zoster-049 在 臨床研究等提出・公開システム 的相關結果
研究名称, 中高年を対象としたZOSTER-049試験（ZOSTER-006/022試験の追跡調査）で接種した帯状疱疹サブユニットワクチンの予防効果、安全性及び免疫応答の持続性評価 ... ... <看更多>
zoster-049 在 COVID-19 and herpes zoster: a call to action 的相關結果
Herpes zoster (HZ), also known as 'shingles', is a vaccine ... Zoster-049 study group. long-term protection against herpes zoster by the ... ... <看更多>
zoster-049 在 老年人带状疱疹疫苗的长期有效性、安全性和免疫反应持久性研究 的相關結果
在ZOSTER-049 研究中（大约在ZOSTER-006/中初次接种疫苗后5 年）对一小群参与者施用1 或2 剂额外剂量（0、2 个月的时间表）的HZ/su 疫苗的免疫原性和安全 ... ... <看更多>
zoster-049 在 Shingles vaccine provides protection for a decade 的相關結果
The interim analysis data from the ZOSTER-049 (ZOE-LTFU) extension ... that the clinical benefit of the Recombinant Zoster Vaccine overall, ... ... <看更多>
zoster-049 在 GSK plans to bring shingles vaccine to India 的相關結果
Shingles (or herpes zoster) is caused by the reactivation of the virus ... These results were from a long-term follow-up study ZOSTER-049 ... ... <看更多>
zoster-049 在 Herpes zoster, il vaccino ricombinante protegge dall'infezione gli 的相關結果
ZOSTER -049 è uno studio di follow-up a lungo termine (LTFU), in aperto, da due studi clinici randomizzati pivotali di fase III (ZOE-50, ZOE-70). ... <看更多>
zoster-049 在 Clinical Trials Register 的相關結果
Herpes Zoster subunit (HZ/su) vaccine and assessment of 1 or 2 additionaldoses on a 0 or 0, 2-month schedule in ... ZOSTER-049 EXT:006-022. ... <看更多>
zoster-049 在 皮膚科英文疾病名稱中文疾病名稱ICD-9-CM 的相關結果
英文疾病名稱 ICD‑9‑CM 1992年版 ICD‑9‑CM 2001年版 A Code
Abscess, cellulitis or lymphadenitis 682.9 682.9 A420
Acanthosis nigricans 701.2 701.2 A429
Acne 706.1 706.1 A429 ... <看更多>
zoster-049 在 最新研究：重组带状疱疹疫苗能为50岁以上成人提供10年保护 的相關結果
葛兰素史克宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护。中期分析数据于2022年10 ... ... <看更多>
zoster-049 在 nRICH 的相關結果
of the Zoster-049 Study Group. The Adjuvanted Recombinant Zoster Vaccine Confers Long-. Term Protection Against Herpes Zoster: Interim Results of an ... ... <看更多>
zoster-049 在 Research Praises Shingles Vaccine Efficacy 的相關結果
The ZOSTER-049 extension study follows 2 pivotal prelicensure phase III randomized clinical trials—known as ZOE-50 and ZOE-70—where RZV ... ... <看更多>
zoster-049 在 How Long Does the Shingles Vaccine Last? 的相關結果
The study, called Zoster-049, is a six-year extension of two, phase III randomized clinical trials (ZOE-50 and ZOE-70). ... <看更多>
zoster-049 在 GSK data shows promising results for Shingrix vaccine ... 的相關結果
Shingles: These results come from ZOSTER-049 (ZOE-LTFU), an extension from two phase III clinical trials ZOE-50 and ZOE-70. ... <看更多>
zoster-049 在 臺北榮民總醫院家庭醫學部 - 2022 的相關結果
... Cunningham AL; Zoster-049 Study Group. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: ... ... <看更多>
zoster-049 在 Potential cost-effectiveness of adjuvanted herpes zoster ... 的相關結果
You, Joyce HS; Ming, Wai-kit; Lee, Chak-fei; Tsang, Owen Tak-yin; Chan, Paul Kay-sheung ;. , ISSN: 0264-410X , 1873-2518; DOI: 10.1016/j.vaccine.2018.06.049 ... ... <看更多>
zoster-049 在 Dados do estudo de extensão ZOSTER-049 demonstram ... 的相關結果
Dados do estudo de extensão ZOSTER-049 demonstram 10 anos de proteção contra o herpes zoster com a vacina recombinante adjuvada da GSK. ... <看更多>
zoster-049 在 Présentation PowerPoint 的相關結果
Phase III and non-interventional studies. ZOSTER-049, 060. ZOSTER-064, 063. ZOSTER-069. ZOSTER-002, 039, 041, 028. ZOSTER-062, 056. EPI-ZOSTER-031. ... <看更多>
zoster-049 在 Shingles Clinical Trials 的相關結果
A Phase 3b, Open-label, Multi-country, Multi-centre, Long-term Follow-up Study of ZOSTER-049 (Follow-up of ZOSTER-006/022 Studies) to Assess the ... ... <看更多>
zoster-049 在 A decade of protection against shingles with Shingrix: Data 的相關結果
GSK recently announced positive interim results from the Zoster-049 extension study showing that overall Shingrix (Zoster vaccine ... ... <看更多>
zoster-049 在 Adjuvanted Zoster Vaccine: Persistent Protection 的相關結果
The adjuvanted recombinant zoster vaccine efficacy is high and ... SOURCE: Boutry C, Hastie A, Diez-Domingo J, et al; Zoster-049 Study Group ... ... <看更多>
zoster-049 在 Myelitis due to Varicella-Zoster Infection in an Adult ... 的相關結果
Abstract. Background: Varicella Zoster Virus (VZV) is a ubiquitous virus and is causing both diseases of varicella and herpes zoster. VZV reactivation may lead ... ... <看更多>
zoster-049 在 Risk of Herpes Zoster in Patients Treated With Long-term ... 的相關結果
https://doi.org/10.1053/j.ajkd.2011.10.049Get rights and content. Background. The risk of herpes zoster in the dialysis population relative to the general ... ... <看更多>
zoster-049 在 Almeno 10 anni di protezione con il vaccino ricombinante ... 的相關結果
21 ottobre - I risultati dello studio ZOSTER-049 mostrano il beneficio clinico a lungo termine del vaccino ricombinante contro l'Herpes ... ... <看更多>
zoster-049 在 October 20, 2017 Approval Letter - SHINGRIX 的相關結果
We have approved your BLA for Zoster Vaccine Recombinant, Adjuvanted effective this ... Study Zoster-049 to assess the long-term efficacy, ... ... <看更多>
zoster-049 在 Long-term Protection Against Herpes Zoster (HZ) by the ... 的相關結果
Paola Pirrotta7, Agnes Mwakingwe-Omari6 on behalf of the Zoster-049 study group. 1Department of Internal Medicine, Korean University College of Medicine, ... ... <看更多>
zoster-049 在 Shingrix can provide at least 10 years of protection against ... 的相關結果
GSK's ZOSTER-049 extension study has shown positive interim results for Shingrix (Zoster Vaccine Recombinant, Adjuvanted). It can provide at ... ... <看更多>
zoster-049 在 A Phase 3 clinical study for patients with Varicella-Zoster ... 的相關結果
Clinical trial for Varicella-Zoster Virus | Herpes Zoster , A Phase 3 clinical ... Long-term Follow-up Study of ZOSTER-049 (Follow-up of ZOSTER-006/022 ... ... <看更多>
zoster-049 在 重组带状疱疹疫苗欣安立适可为50岁及以上成人提供至少10 ... 的相關結果
近日，葛兰素史克（GSK）宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护。 ... <看更多>
zoster-049 在 Shingrix 可以为50 岁及以上的成年人提供至少10 年的带状 ... 的相關結果
GSK plc 宣布ZOSTER-049 扩展研究的积极中期结果表明，在初次接种疫苗后，整体Shingrix(带状疱疹疫苗重组，佐剂)可以提供至少十年的带状疱疹(带状 ... ... <看更多>
zoster-049 在 Shingrix Shingles Vaccine 的相關結果
ZOSTER -049 is an open-label, long-term follow-up study from two pivotal phase III randomized clinical trials (ZOE-50, ZOE-70). ... <看更多>
zoster-049 在 進行中臨床試驗案件查詢 的相關結果
一項第3b 期、開放性、多國、多中心、ZOSTER-049 試驗（ZOSTER-006/022 試驗的追蹤）的長期追蹤試驗，評估帶狀皰疹次單位疫苗的預防性效力、安全性和免疫反應持續性， ... ... <看更多>
zoster-049 在 Andrew Hastie 的相關結果
The adjuvanted recombinant zoster vaccine (RZV) confers long-term protection against herpes zoster: interim results of an extension study (ZOSTER-049) of Two ... ... <看更多>
zoster-049 在 Innovazione nella vaccinazione anti-HZ 的相關結果
Herpes Zoster: dermatite vescicolosa acuta, a tipica distribuzione ... Risultato dall'analisi ad interim dello studio di estensione Zoster-049. ... <看更多>
zoster-049 在 Clinical trials detail : MGeND 的相關結果
- Subjects with a new onset of a pIMD or exacerbation of a pIMD from first vaccination in the previous ZOSTER-006/022 studies to enrolment in study ZOSTER-049. ... <看更多>
zoster-049 在 Plotkin's Vaccines,E-Book - 第 1349 頁 - Google 圖書結果 的相關結果
Immunogenicity of the adjuvanted recombinant zoster vaccine : persistence and ... her- pes zoster : Interim results of an extension study ( Zoster -049 ) of ... ... <看更多>
zoster-049 在 药企布局带状疱疹疫苗，目前研发进展如何 的相關結果
以上结果来自两项三期临床试验Zoster-006(ZOE-50)和Zoster-022(ZOE-70)的扩展研究ZOSTER-049(ZOE-LTFU)，后者旨在对Zoster-006和Zoster-022临床试验的 ... ... <看更多>
zoster-049 在 Ministero della Salute 的相關結果
OGGETTO: Aggiornamento sulla vaccinazione contro Herpes zoster ... Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials ... ... <看更多>
zoster-049 在 cdOtsinguTulemus 的相關結果
50 years of age with a prior episode of Herpes Zoster ... 66, 19-049, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. MK-3475-975 ... ... <看更多>
zoster-049 在 GSK comunica datos de duración de la protección ... 的相關結果
El ensayo ZOSTER-049 (ZOE-LTFU) es una extensión de dos ensayos clínicos fase II (ZOE-50 y ZOE-70) y en sí, es una prolongación abierta de ... ... <看更多>
zoster-049 在 La vacunación del herpes zóster cada vez más extendida y ... 的相關結果
Hace pocos días se ha presentado el análisis intermedio del estudio Zoster-049, recientemente publicado en el Open Forum Infectious Diseases ... ... <看更多>
zoster-049 在 The Adjuvanted Recombinant Zoster Vaccine Confers ... 的相關結果
Zoster -049 Study Group , Céline Boutry, Andrew Hastie, Javier Diez-Domingo, Juan Carlos Tinoco, Chong Jen Yu, Charles Andrews, Jean Beytout, Covadonga Caso, ... ... <看更多>
zoster-049 在 Cost-effectiveness of the recombinant zoster vaccine (RZV) ... 的相關結果
Out of 18 selected studies, RZV vaccination against herpes zoster and post-herpetic neuralgia is ... 2018;36(31):4610–20. doi:10.1016/j.vaccine.2018.06.049. ... <看更多>
zoster-049 在 Herpes Zoster and Diabetes Mellitus: A Review 的相關結果
On the other hand, a novel vaccine against varicella-zoster virus (VZV) was recently introduced in clinical practice. ... 2014;1:ofu049. ... <看更多>
zoster-049 在 Status of Herpes Zoster and Herpes Zoster Vaccines in 2023 的相關結果
La infección por herpes zoster (HZ) es un importante pro- blema de salud pública, por su elevada incidencia y ... 10.1053/j.ajkd.2011.10.049. ... <看更多>
zoster-049 在 Water-borne Commerce of the United States 的相關結果
... FRESH SHELLFISH AND PRODUCTS LUMBER AND SHINGLES 049 413 HALFMOON BAY CALIF 040 FISH AND PRODUCTS , FRESH 049 SHELLFISH AND PRODUCTS COYOTE HILL SLOUGH ... ... <看更多>
zoster-049 在 Recombinant zoster vaccine for immunocompromised people 的相關結果
The live attenuated zoster vaccine recommended for immunocompetent adults is ... Boutry C, Hastie A, Diez-Domingo J, et al; Zoster-049 Study Group. ... <看更多>
zoster-049 在 Increased Risk of Stroke After a Herpes Zoster Attack 的相關結果
Background and Purpose— Varicella zoster virus-induced vasculopathy and postherpes zoster attack stroke syndromes have been reported ... ... <看更多>
zoster-049 在 最新研究数据显示：重组带状疱疹疫苗欣安立适能为50岁及以上 ... 的相關結果
中新网上海新闻10月21日电(记者陈静)记者21日从葛兰素史克(GSK)获悉，ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够 ... ... <看更多>
zoster-049 在 关注 的相關結果
上海2022年10月21日-- 葛兰素史克（GSK）今日宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护[1]。 ... <看更多>
zoster-049 在 protocolo de vacunación frente al virus herpes zóster en ... 的相關結果
Fuente: Grupo de trabajo de vacunación frente a herpes zóster de la Ponencia de ... En los estudios de extensión (Zoster-049) se observa una alta eficacia. ... <看更多>
zoster-049 在 重组带状疱疹疫苗欣安立适能够为50岁及以上成人提供至少 ... 的相關結果
葛兰素史克（GSK）今天宣布ZOSTER-049扩展研究取得积极中期结果：初次接种重组带状疱疹疫苗欣安立适后能够提供至少10年的带状疱疹保护。 重组带状疱疹 ... ... <看更多>
zoster-049 在 Varicella Zoster Virus ORF25 Gene Product: An Essential Hub ... 的相關結果
The beneficial effects of varicella zoster virus. Journal of Hematology and Clinical Research 2019, 3 (1) , 016-049. ... <看更多>
zoster-049 在 2014 ICD-9-CM for Hospitals, Volumes 1, 2 and 3 Professional ... 的相關結果
Chickenpox. NOS is reported with 052.9. Includes shingles ZOrla 053.0 With meningitiso (3)003:21,013,0001316,0360,047.0.0479,049,0.0491,053.0053.19 ... ... <看更多>
zoster-049 在 Shingrix protege durante "al menos 10 años" contra ... 的相關結果
Los resultados preliminares del estudio ZOSTER-049 de GSK muestran que Shingrix (vacuna recombinante contra el herpes zoster, con adyuvante) ... ... <看更多>
zoster-049 在 Detailed Diagnoses and Procedures, National Hospital ... 的相關結果
... NERVOUS SYSTEM .9 044 SEPTICEMIA DUE TO SERRATIA 049 .8 OTHER SEPTICEMIA ... .9 054 HERPES ZOSTER HERPES ZOSTER WITH MENINGITIS HERPES ZOSTER WITH OTHER ... ... <看更多>
zoster-049 在 Vital Statistics of the United States 的相關結果
o o Other enterovirus diseases of central nervous system ( 048 ) 0 ( 049 ) . ... Herpes zoster without mention of complication ( 053 . 9 ) . ... <看更多>
zoster-049 在 prevenzione dell'herpes zoster nell'anziano 的相關結果
Pazienti fragili e impatto dell'Herpes Zoster ... Risultato dall'analisi ad interim dello studio di estensione Zoster-049. 1. Hastie A, et al. ... <看更多>
zoster-049 在 Perceived psychological stress and risk of herpes zoster: a ... 的相關結果
Perceived psychological stress and risk of herpes zoster: a ... Mean age was 58 years (SE 0·049) and sex was equally distributed (Table 1). ... <看更多>
zoster-049 在 a population-based study using health system integrated ... 的相關結果
Estimate the incidence of herpes zoster (HZ), its complications and ... Herpes zoster risk and burden of disease in immunocompromised ... ... <看更多>
zoster-049 在 Langzeitschutz vor Herpes zoster hält mindestens 10 Jahre 的相關結果
Die Ergebnisse stammen aus der Studie ZOSTER-049 (ZOE-LTFU, Langzeit-Follow-up), einer Erweiterung von zwei klinischen Phase-III-Studien (ZOE-50 ... ... <看更多>
zoster-049 在 Studie: Ny vaksine mot helvetesild gir minst 10 års beskyttelse 的相關結果
Studien som heter ZOSTER-049 dokumenterer at Shingrix gir over 80 prosent beskyttelse mot den smertefulle sykdommen i mer enn 10 år for de ... ... <看更多>
zoster-049 在 成人対象P3試験で少なくとも10年間の帯状疱疹への予防効果 ... 的相關結果
英グラクソ・スミスクラインは、帯状疱疹予防ワクチン「シングリックス（乾燥組換え帯状疱疹ワクチン）」について、ZOSTER-049試験で良好な中間結果が ... ... <看更多>
zoster-049 在 带状疱疹疫苗！Shingrix(欣安立适)：在≥50岁老年人群中 的相關結果
图片来源：摄图网. 2022年10月25日讯/生物谷BIOON/ --葛兰素史克（GSK）近日在2022年美国感染性疾病周（IDWeek 2022）上公布了ZOSTER-049扩展研究的 ... ... <看更多>
zoster-049 在 New data show Shingrix can provide at least 10 years of ... 的相關結果
Shingles is caused by the reactivation of the varicella zoster ... from the ZOSTER-049 extension study showing that overall Shingrix (Zoster ... ... <看更多>
zoster-049 在 La vacuna contra el herpes de GSK proporciona al menos ... 的相關結果
... Vacuna Recombinante Adyuvada Frente Al Herpes Zóster De GSK. ... provisionales del estudio de seguimiento a largo plazo 'ZOSTER-049', ... ... <看更多>
zoster-049 在 Detail klinického hodnocení 的相關結果
Název studie, Otevřené, mezinárodní, multicentrické, klinické hodnocení fáze 3b v rámci dlouhodobého sledování navazujícího na klinické hodnocení ZOSTER-049 ... ... <看更多>
zoster-049 在 Interim Results of an Extension Study (ZOSTER-049) ... 的相關結果
Primary objective: VE against HZ over the ZOSTER-049 study. Secondary objectives: VE against HZ from 1 month post-dose 2 in ZOE-50/-70 until ... ... <看更多>